Latest Reimbursement News

EBR Systems secures Priority Review from Australia's TGA for its wireless cardiac pacing system, fast-tracking regulatory approval and expanding access for heart failure patients. This follows strong US commercial momentum after FDA approval.

Phoslock Environmental Technologies reported a stable sales volume and improved cash flow compared to last year, while ramping up production after reopening its Chinese factory. The company is advancing R&D on a new lanthanum product and faces ongoing legal challenges with mediation set for June.

BCAL Diagnostics has expanded its Avantect cancer blood tests nationally through major pathology networks, generating $88,000 in Q3 revenue from 91 tests. The company also submitted an initial Medicare reimbursement application for pancreatic cancer detection and is preparing to launch an enhanced BREASTESTplus 2.0 test in early 2027.

Critica Limited has produced its first commercial-quality Mixed Rare Earth Carbonate at 58% TREO, confirming a refinery-aligned product pathway, while launching a major resource upgrade drilling program at its Jupiter Rare Earths Project in Western Australia.

Galileo Mining maintains a strong cash position of approximately A$8.2 million as it confirms extensive PGE-nickel-copper mineralisation at Norseman's Mission Sill and completes deep diamond drilling beneath the Callisto deposit.

Lindian Resources has locked in a US$11.6 million financing package from Malawi's NBS Bank, bolstering the Kangankunde Rare Earths Project with asset-backed and working capital facilities. This deal complements Lindian’s recent A$100 million placement and underscores its commitment to local partnerships.

4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.

Worley Limited reveals the ongoing Middle East conflict is causing significant project delays and an estimated $30 to $40 million hit to FY26 underlying EBITA, prompting a revision to its growth outlook.

Channel Infrastructure has locked in a government contract for 93 million litres of additional diesel storage at Marsden Point, adding about $8 million revenue in 2026 and reinforcing its role in New Zealand’s fuel security.

PainChek has secured a landmark agreement with Sabra Health Care REIT to deploy its AI-powered pain assessment across up to 20,000 beds in North America, marking a pivotal step in its US expansion.

Diatreme Resources is consolidating its Far North Queensland silica assets by selling the Cape Flattery Silica Project to its joint venture with Sibelco, securing $7.4 million in fresh capital and streamlining project ownership ahead of key development milestones.